Interleukin-1 Receptor Blockade Rescues Myocarditis-Associated End-Stage Heart Failure

Support measures currently represent the mainstay of treatment for fulminant myocarditis, while effective and safe anti-inflammatory therapies remain an unmet clinical need. However, clinical and experimental evidence indicates that inhibition of the pro-inflammatory cytokine interleukin 1 (IL-1) is...

Descripción completa

Detalles Bibliográficos
Autores principales: Cavalli, Giulio, Foppoli, Marco, Cabrini, Luca, Dinarello, Charles A., Tresoldi, Moreno, Dagna, Lorenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5298961/
https://www.ncbi.nlm.nih.gov/pubmed/28232838
http://dx.doi.org/10.3389/fimmu.2017.00131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5298961/
https://www.ncbi.nlm.nih.gov/pubmed/28232838
http://dx.doi.org/10.3389/fimmu.2017.00131

Ejemplares similares